Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis.

de Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewé R, van der Leij C, Maas M, Serre G, van Schaardenburg D, Klareskog L, Gerlag DM, van Baarsen LG, Tak PP.

Arthritis Rheumatol. 2014 Mar;66(3):513-22. doi: 10.1002/art.38273.

2.

Expression of Prostaglandin E2 Enzymes in the Synovium of Arthralgia Patients at Risk of Developing Rheumatoid Arthritis and in Early Arthritis Patients.

de Hair MJ, Leclerc P, Newsum EC, Maijer KI, van de Sande MG, Ramwadhdoebe TH, van Schaardenburg D, van Baarsen LG, Korotkova M, Gerlag DM, Tak PP, Jakobsson PJ.

PLoS One. 2015 Jul 30;10(7):e0133669. doi: 10.1371/journal.pone.0133669. eCollection 2015.

3.

Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.

Cantaert T, Brouard S, Thurlings RM, Pallier A, Salinas GF, Braud C, Klarenbeek PL, de Vries N, Zhang Y, Soulillou JP, Tak PP, Baeten D.

Arthritis Rheum. 2009 Jul;60(7):1944-56. doi: 10.1002/art.24635.

4.

Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis.

Sokolove J, Johnson DS, Lahey LJ, Wagner CA, Cheng D, Thiele GM, Michaud K, Sayles H, Reimold AM, Caplan L, Cannon GW, Kerr G, Mikuls TR, Robinson WH.

Arthritis Rheumatol. 2014 Apr;66(4):813-21. doi: 10.1002/art.38307.

5.

Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.

Young KA, Deane KD, Derber LA, Hughes-Austin JM, Wagner CA, Sokolove J, Weisman MH, Buckner JH, Mikuls TR, O'Dell JR, Keating RM, Gregersen PK, Robinson WH, Holers VM, Norris JM.

Arthritis Rheum. 2013 Aug;65(8):1995-2004. doi: 10.1002/art.38022.

6.

Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis.

Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D.

Arthritis Rheum. 2013 Apr;65(4):911-5. doi: 10.1002/art.37830.

7.

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.

Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716.

8.

Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase.

van de Sande MG, de Hair MJ, van der Leij C, Klarenbeek PL, Bos WH, Smith MD, Maas M, de Vries N, van Schaardenburg D, Dijkmans BA, Gerlag DM, Tak PP.

Ann Rheum Dis. 2011 May;70(5):772-7. doi: 10.1136/ard.2010.139527. Epub 2010 Dec 21.

PMID:
21177292
9.

Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.

Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, Engström M, Grunewald J, Nyren S, Eklund A, Klareskog L, Sköld CM, Catrina AI.

Arthritis Rheumatol. 2014 Jan;66(1):31-9. doi: 10.1002/art.38201.

10.

Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.

Wagner CA, Sokolove J, Lahey LJ, Bengtsson C, Saevarsdottir S, Alfredsson L, Delanoy M, Lindstrom TM, Walker RP, Bromberg R, Chandra PE, Binder SR, Klareskog L, Robinson WH.

Ann Rheum Dis. 2015 Mar;74(3):579-86. doi: 10.1136/annrheumdis-2013-203915. Epub 2013 Dec 2.

11.

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Thiele GM, Duryee MJ, Anderson DR, Klassen LW, Mohring SM, Young KA, Benissan-Messan D, Sayles H, Dusad A, Hunter CD, Sokolove J, Robinson WH, O'Dell JR, Nicholas AP, Tuma DJ, Mikuls TR.

Arthritis Rheumatol. 2015 Mar;67(3):645-55. doi: 10.1002/art.38969.

12.

Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis.

van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM.

Arthritis Rheum. 2008 Jan;58(1):53-60. doi: 10.1002/art.23148.

13.

Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis.

Schuerwegh AJ, Ioan-Facsinay A, Dorjée AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE.

Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2586-91. doi: 10.1073/pnas.0913054107. Epub 2010 Jan 25. Retraction in: Schuerwegh AJ, Ioan-Facsinay A, Dorjee AL, Roos J, Bajema IM, van der Voort EI, Huizinga TW, Toes RE. Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20345.

14.

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and -negative rheumatoid arthritis patients.

Gómez-Puerta JA, Celis R, Hernández MV, Ruiz-Esquide V, Ramírez J, Haro I, Cañete JD, Sanmartí R.

Arthritis Res Ther. 2013 Nov 7;15(6):R182. doi: 10.1186/ar4372.

15.

Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype.

Thurlings RM, Wijbrandts CA, Mebius RE, Cantaert T, Dinant HJ, van der Pouw-Kraan TC, Verweij CL, Baeten D, Tak PP.

Arthritis Rheum. 2008 Jun;58(6):1582-9. doi: 10.1002/art.23505.

16.

The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.

da Mota LM, Dos Santos Neto LL, de Carvalho JF, Pereira IA, Burlingame R, Ménard HA, Laurindo IM.

Rheumatol Int. 2012 Dec;32(12):3807-12. doi: 10.1007/s00296-011-2260-9. Epub 2011 Dec 21.

PMID:
22187055
17.

Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study.

Arkema EV, Goldstein BL, Robinson W, Sokolove J, Wagner CA, Malspeis S, Rosner B, Grodstein F, Karlson EW, Costenbader KH.

Arthritis Res Ther. 2013 Oct 23;15(5):R159. doi: 10.1186/ar4342.

18.

Citrullination of synovial proteins in murine models of rheumatoid arthritis.

Vossenaar ER, Nijenhuis S, Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA.

Arthritis Rheum. 2003 Sep;48(9):2489-500.

19.

Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.

Gonzalez SM, Payne JB, Yu F, Thiele GM, Erickson AR, Johnson PG, Schmid MJ, Cannon GW, Kerr GS, Reimold AM, Sokolove J, Robinson WH, Mikuls TR.

J Periodontol. 2015 Feb;86(2):222-31. doi: 10.1902/jop.2014.140425. Epub 2014 Oct 9.

PMID:
25299390
20.

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis.

Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Rönnelid J, Rantapää-Dahlqvist S.

Arthritis Res Ther. 2011 Feb 3;13(1):R13. doi: 10.1186/ar3237.

Items per page

Supplemental Content

Write to the Help Desk